Medical management of chronic occlusive arterial disease.
D000925:Anticoagulants / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000628:therapy*; D001161:Arteriosclerosis / Q000188:drug therapy; D002908:Chronic Disease; D048909:Diabetes Complications; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005734:Gangrene / Q000628:therapy; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D006973:Hypertension / Q000150:complications; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007871:Leg Ulcer / Q000628:therapy; D011086:Polycythemia / Q000150:complications; D012907:Smoking / Q000150:complications; D013927:Thrombosis / Q000209:etiology; D014665:Vasodilator Agents / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D000960:Hypolipidemic Agents; D014665:Vasodilator Agents